P
Prajnan Das
Researcher at University of Texas MD Anderson Cancer Center
Publications - 317
Citations - 12590
Prajnan Das is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Radiation therapy & Cancer. The author has an hindex of 45, co-authored 276 publications receiving 9801 citations. Previous affiliations of Prajnan Das include University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
Monique Maas,Patty J. Nelemans,Vincenzo Valentini,Prajnan Das,Claus Rödel,Li Jen Kuo,Felipe A. Calvo,Julio Garcia-Aguilar,Rob Glynne-Jones,Karin Haustermans,Mohammed Mohiuddin,Salvatore Pucciarelli,William Small,Javier Suárez,George Theodoropoulos,Sebastiano Biondo,Sebastiano Biondo,Regina G. H. Beets-Tan,Geerard L. Beets +18 more
TL;DR: Patients with pCR after chemoradiation have better long-term outcome than do those without pCR, and pCR might be indicative of a prognostically favourable biological tumour profile with less propensity for local or distant recurrence and improved survival.
Journal ArticleDOI
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Jaffer A. Ajani,Thomas A. D'Amico,David J. Bentrem,Joseph Chao,Carlos U. Corvera,Prajnan Das,Crystal S. Denlinger,Peter C. Enzinger,Paul T. Fanta,Farhood Farjah,Hans Gerdes,Michael Gibson,Robert E. Glasgow,James A. Hayman,Steven N. Hochwald,Wayne L. Hofstetter,David H. Ilson,Dawn E. Jaroszewski,Kimberly L. Johung,Rajesh N. Keswani,Lawrence Kleinberg,Stephen Leong,Quan P. Ly,Kristina A. Matkowskyj,Michael McNamara,Mary F. Mulcahy,Ravi Kumar Paluri,Haeseong Park,Kyle A. Perry,Jose M. Pimiento,George A. Poultsides,Robert E. Roses,Vivian E. Strong,Georgia L. Wiesner,Christopher G. Willett,Cameron D. Wright,Nicole R. McMillian,Lenora A. Pluchino +37 more
TL;DR: This selection from the NCCN Guidelines for Esophageal and Esophagogastric Junction Cancers focuses on recommendations for the management of locally advanced and metastatic adenocarcinoma of the esophagus and EGJ.
Journal ArticleDOI
Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology
Jaffer A. Ajani,Thomas A. D'Amico,Khaldoun Almhanna,David J. Bentrem,Joseph Chao,Prajnan Das,Crystal S. Denlinger,Paul T. Fanta,Farhood Farjah,Charles S. Fuchs,Hans Gerdes,Michael K. Gibson,Robert E. Glasgow,James A. Hayman,Steven N. Hochwald,Wayne L. Hofstetter,David H. Ilson,Dawn E. Jaroszewski,Kimberly L. Johung,Rajesh N. Keswani,Lawrence Kleinberg,W. Michael Korn,Stephen Leong,Catherine Linn,A. Craig Lockhart,Quan P. Ly,Mary F. Mulcahy,Mark B. Orringer,Kyle A. Perry,George A. Poultsides,Walter J. Scott,Vivian E. Strong,Mary Kay Washington,Benny Weksler,Christopher G. Willett,Cameron D. Wright,Debra Zelman,Nicole R. McMillian,Hema Sundar +38 more
TL;DR: The recommendations outlined in the NCCN Guidelines for staging, assessment of HER2 overexpression, systemic therapy for locally advanced or metastatic disease, and best supportive care for the prevention and management of symptoms due to advanced disease are discussed.
Journal ArticleDOI
Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head
Gauri R. Varadhachary,Robert A. Wolff,Christopher H. Crane,Charlotte C. Sun,Jeffrey E. Lee,Peter W.T. Pisters,Jean Nicolas Vauthey,Eddie K. Abdalla,Huamin Wang,Gregg A Staerkel,Jeffrey H. Lee,William A. Ross,Eric P. Tamm,Priya Bhosale,Sunil Krishnan,Prajnan Das,Linus Ho,Henry Xiong,James L. Abbruzzese,Douglas B. Evans +19 more
TL;DR: Preoperative Gem-Cis-XRT did not improve survival beyond that achieved with preoperative gemcitabine-based chemoradiation (Gem- XRT) alone, and the Gem-X RT platform is a reasonable foundation on which to build future phase II multimodality trials for stage I/II pancreatic cancer incorporating emerging systemic therapies.
Journal ArticleDOI
Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: A Radiation Therapy Oncology Group Consensus Panel Contouring Atlas
Robert J. Myerson,Michael C. Garofalo,Issam El Naqa,Ross A. Abrams,Aditya Apte,Walter R. Bosch,Prajnan Das,Leonard L. Gunderson,Theodore S. Hong,J.J. John Kim,Christopher G. Willett,Lisa A. Kachnic +11 more
TL;DR: This report serves as a template for the definition of the elective CTVs to be used in IMRT planning for anal and rectal cancers, as part of prospective RTOG trials.